Literature DB >> 15453884

Urinary tract infection in the users of depot-medroxyprogesterone acetate.

Saeideh Ziaei1, Mojgane Ninavaei, Soghrate Faghihzadeh.   

Abstract

BACKGROUND: The effects of progesterone on muscle tone, peristalsis of the ureter and also urinary vasculature may cause urinary tract infection (UTI) in women who use depot-medroxyprogesterone acetate (DMPA) for contraception.
METHODS: In a cohort study, 200 women who chose DMPA for contraception were compared with 200 women who used the withdrawal method for urinary infection and urological symptoms after 3 months of consumption.
RESULTS: The rate of urinary infection and urological symptoms in the study group were higher than in the control group (p = 0.018, p < 0.0001, respectively). The most common microorganism that caused urinary infection was Escherichia coli. Among the 10 cases who suffered UTI in the case group, there were six women who had UTI in the previous pregnancy as well.
CONCLUSION: We do not recommended administering depot-medroxyprogesterone acetate for contraception in women with a history of urinary tract infection in a previous pregnancy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15453884     DOI: 10.1111/j.0001-6349.2004.00296.x

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  2 in total

Review 1.  The diagnosis of urinary tract infection: a systematic review.

Authors:  Guido Schmiemann; Eberhardt Kniehl; Klaus Gebhardt; Martha M Matejczyk; Eva Hummers-Pradier
Journal:  Dtsch Arztebl Int       Date:  2010-05-28       Impact factor: 5.594

Review 2.  Innate Bacteriostatic Mechanisms Defend the Urinary Tract.

Authors:  Jose A Munoz; Anne-Catrin Uhlemann; Jonathan Barasch
Journal:  Annu Rev Physiol       Date:  2021-11-15       Impact factor: 22.163

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.